NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIBIB E-054-2018-0-EP-04 CHEMICAL CONJUGATES OF EVANS BLUE DERIVATIVES AND THEIR USE AS RADIOTHERAPY AND IMAGING AGENTS FOR TARGETING PROSTATE CANCER EP National Stage 19756548.4 Pending
NIBIB E-054-2018-0-IE-01 CHEMICAL CONJUGATES OF EVANS BLUE DERIVATIVES AND THEIR USE AS RADIOTHERAPY AND IMAGING AGENTS FOR TARGETING PROSTATE CANCER IE National Stage 19756548.4 Pending
NIBIB E-054-2018-0-DE-01 CHEMICAL CONJUGATES OF EVANS BLUE DERIVATIVES AND THEIR USE AS RADIOTHERAPY AND IMAGING AGENTS FOR TARGETING PROSTATE CANCER DE National Stage 19756548.4 Pending
NIBIB E-054-2018-0-CH-01 CHEMICAL CONJUGATES OF EVANS BLUE DERIVATIVES AND THEIR USE AS RADIOTHERAPY AND IMAGING AGENTS FOR TARGETING PROSTATE CANCER CH National Stage 19756548.4 Pending
NIBIB E-054-2018-0-ES-01 CHEMICAL CONJUGATES OF EVANS BLUE DERIVATIVES AND THEIR USE AS RADIOTHERAPY AND IMAGING AGENTS FOR TARGETING PROSTATE CANCER ES National Stage 19756548.4 Pending
NIBIB E-054-2018-0-FR-01 CHEMICAL CONJUGATES OF EVANS BLUE DERIVATIVES AND THEIR USE AS RADIOTHERAPY AND IMAGING AGENTS FOR TARGETING PROSTATE CANCER FR National Stage 19756548.4 Pending
NIBIB E-054-2018-0-IT-01 CHEMICAL CONJUGATES OF EVANS BLUE DERIVATIVES AND THEIR USE AS RADIOTHERAPY AND IMAGING AGENTS FOR TARGETING PROSTATE CANCER IT National Stage 19756548.4 Pending
NIBIB E-054-2018-0-CA-09 CHEMICAL CONJUGATES OF EVANS BLUE DERIVATIVES AND THEIR USE AS RADIOTHERAPY AND IMAGING AGENTS FOR TARGETING PROSTATE CANCER CA National Stage 3090812 Pending
NIAID E-034-2018-0-PCT-01 NEUTRALIZING ANTIBODIES TO HIV-1 ENV AND THEIR USE PCT PCT COMB PCT/US2019/019021 Expired
NIAID E-034-2018-0-CN-04 NEUTRALIZING ANTIBODIES TO HIV-1 ENV AND THEIR USE CN National Stage 201980025868.8 Pending
NIAID E-034-2018-0-EP-05 NEUTRALIZING ANTIBODIES TO HIV-1 ENV AND THEIR USE EP National Stage 19709330.5 Pending
NIAID E-034-2018-0-CA-03 NEUTRALIZING ANTIBODIES TO HIV-1 ENV AND THEIR USE CA National Stage 3091437 Pending
NIAID E-034-2018-0-ZA-09 NEUTRALIZING ANTIBODIES TO HIV-1 ENV AND THEIR USE ZA National Stage 2020/05183 Pending
NIAID E-034-2018-0-RU-07 NEUTRALIZING ANTIBODIES TO HIV-1 ENV AND THEIR USE RU National Stage 2020130795 Pending
NIAID E-034-2018-0-IN-06 NEUTRALIZING ANTIBODIES TO HIV-1 ENV AND THEIR USE IN National Stage 202037039570 Pending
NIAID E-034-2018-0-AU-02 NEUTRALIZING ANTIBODIES TO HIV-1 ENV AND THEIR USE AU National Stage 2019226034 Abandoned
NIBIB E-006-2016-0-US-04 SYSTEMS AND METHODS FOR INSTANT TOTAL INTERNAL REFLECTION FLUORESCENCE/ STRUCTURED ILLUMINATION MICROSCOPY US National Stage 16/326,757 1052-07-14 Abandoned PDF
NCATS E-020-2016-0-US-10 Antifungal Compound Process US DIV 16/280,534 10428025 Abandoned PDF
NCATS E-020-2016-0-US-09 Antifungal Compound Process US DIV 16/280,527 10407392 Issued PDF
NHLBI E-064-2018-0-CN-03 Inner Curvature Charge Concentration Device For Tissue Laceration CN National Stage 201980008535.4 Abandoned
NCATS E-262-2016-0-US-05 SUBSTITUTED IMIDAZO[1,2-A]PYRIDINES AS IRAK-4 INHIBITORS US National Stage 16/326,571 11254667 Abandoned PDF
NHLBI E-064-2018-0-PCT-02 Inner Curvature Charge Concentration Device For Tissue Laceration PCT PCT PCT/US2019/018503 Expired
NIAID E-035-2018-0-PCT-01 TREATMENT OF INFECTIONS AND IMMUNE DYSREGULATION IN PATIENTS WITH PRIMARY IMMUNE DEFICIENCIES USING MRNA-CORRECTED AUTOLOGOUS GRANULOCYTES, LYMPHOCYTES AND/OR NATURAL KILLER CELLS PCT PCT COMB PCT/US2019/018606 Expired
NIAID E-035-2018-0-HK-04 TREATMENT OF INFECTIONS AND IMMUNE DYSREGULATION IN PATIENTS WITH PRIMARY IMMUNE DEFICIENCIES USING MRNA-CORRECTED AUTOLOGOUS
GRANULOCYTES, LYMPHOCYTES AND/OR NATURAL KILLER CELLS 		HK EP 62021032425.2 Pending
NHLBI E-064-2018-0-EP-04 Inner Curvature Charge Concentration Device For Tissue Laceration EP National Stage 19756527.8 Abandoned
NIAID E-035-2018-0-EP-02 TREATMENT OF INFECTIONS AND IMMUNE DYSREGULATION IN PATIENTS WITH PRIMARY IMMUNE DEFICIENCIES USING MRNA-CORRECTED AUTOLOGOUS GRANULOCYTES, LYMPHOCYTES AND/OR NATURAL KILLER CELLS EP National Stage 19709243.0 Pending
NICHD E-120-2015-0-IL-58 Method For On-demand Contraception IL DIV 264867 Abandoned
NLM E-124-2017-1-US-03 METHODS FOR IDENTIFYING CLASS 2 CRISPR-CAS SYSTEMS US National Stage 16/326,132 1243-12-16 Issued PDF
NCI E-046-2019-0-CA-03 Non-aggregating Heptamethine Cyanine Fluorophores For In Vivo Imaging CA National Stage 3090797 Issued
NCI E-046-2019-0-AU-02 Non-aggregating Heptamethine Cyanine Fluorophores For In Vivo Imaging AU National Stage 2019222477 Issued
NCI E-046-2019-0-SE-13 Non-aggregating Heptamethine Cyanine Fluorophores For In Vivo Imaging SE EP 19711727.8 Issued
NCI E-046-2019-0-CH-08 Non-aggregating Heptamethine Cyanine Fluorophores For In Vivo Imaging CH EP 19711727.8 Issued
NCI E-046-2019-0-NL-12 Non-aggregating Heptamethine Cyanine Fluorophores For In Vivo Imaging NL EP 19711727.8 Issued
NCI E-046-2019-0-DE-09 Non-aggregating Heptamethine Cyanine Fluorophores For In Vivo Imaging DE EP 19711727.8 Issued
NCI E-046-2019-0-FR-10 Non-aggregating Heptamethine Cyanine Fluorophores For In Vivo Imaging FR EP 19711727.8 Issued
NCI E-046-2019-0-EP-04 Non-aggregating Heptamethine Cyanine Fluorophores For In Vivo Imaging EP National Stage 19711727.8 Issued
NCI E-046-2019-0-GB-11 Non-aggregating Heptamethine Cyanine Fluorophores For In Vivo Imaging GB EP 19711727.8 Issued
NCI E-046-2019-0-JP-05 Non-aggregating Heptamethine Cyanine Fluorophores For In Vivo Imaging JP National Stage 2020-543358 Issued
NCI E-046-2019-0-PCT-01 Non-aggregating Heptamethine Cyanine Fluorophores For In Vivo Imaging PCT PCT PCT/US2019/018153 Expired
NEI E-134-2016-0-US-07 SELECTIVE ESTROGEN-RECEPTOR MODULATORS (SERMS) CONFER PROTECTION AGAINST
PHOTORECEPTOR DEGENERATION 		US National Stage 16/325,678 11040019 Issued PDF
NCI E-036-2018-0-PCT-02 HEPTAMETHINE CYANINES FOR USE AS FLUORESCENT MARKERS OF THE BILIARY AND RENAL SYSTEMS PCT PCT PCT/US2019/018057 Expired
NCI E-036-2018-0-EP-05 HEPTAMETHINE CYANINES FOR USE AS FLUORESCENT MARKERS OF THE BILIARY AND RENAL SYSTEMS EP National Stage 19754834.0 Abandoned
NCI E-036-2018-0-JP-06 HEPTAMETHINE CYANINES FOR USE AS FLUORESCENT MARKERS OF THE BILIARY AND RENAL SYSTEMS JP National Stage 2020-543808 Abandoned
NCI E-036-2018-0-CA-07 HEPTAMETHINE CYANINES FOR USE AS FLUORESCENT MARKERS OF THE BILIARY AND RENAL SYSTEMS CA National Stage 3091423 Abandoned
CC E-001-2019-0-US-01 Handgrip Relaxometer Devices US 62/805,750 Abandoned
NCI E-190-2014-0-GB-01 VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF
TUMORS 		GB EP 19156541.5 Issued
NCI E-190-2014-0-EP-14 VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF
TUMORS 		EP DIV 19156541.5 Issued
NCI E-190-2014-0-IT-01 VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF
TUMORS 		IT EP 19156541.5 Issued
NCI E-190-2014-0-ES-01 VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF
TUMORS 		ES EP 19156541.5 Issued
NCI E-190-2014-0-FR-01 VIRUS-LIKE PARTICLE CONJUGATES FOR DIAGNOSIS AND TREATMENT OF
TUMORS 		FR EP 19156541.5 Issued